Gypenoside L and Gypenoside LI Inhibit Proliferation in Renal Cell Carcinoma via Regulation of the MAPK and Arachidonic Acid Metabolism Pathways

• Main Authors: Hui Liu (Author), Xiuming Li (Author), Jinbo Xie (Author), Chengcheng Lv (Author), Fangchao Lian (Author), Shouyi Zhang (Author), Yu Duan (Author), Yu Zeng (Author), Xianglan Piao (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Renal cell carcinoma (RCC) has the highest mortality rate of all urological malignancies. Clear cell renal cell carcinoma (ccRCC) accounts for approximately 80% of all RCC cases and is often accompanied by the accumulation of lipid droplets. Growing evidence indicates that ccRCC is a metabolism-rela...